Investigating how sugary and artificially sweetened beverages affect diabetes risk factors
Proteomic and integrative omic profiles of sugar- and artificially sweetened beverage consumption and changes in type 2 diabetes risk factors
This study is looking at how drinking sugary and artificially sweetened drinks might affect your risk of developing type 2 diabetes, and it aims to help people understand how their beverage choices can impact their health.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10910142 on NIH RePORTER |
What this research studies
This research explores the relationship between the consumption of sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) and the risk factors associated with type 2 diabetes (T2D). By analyzing blood samples for proteomic and multi-omic profiles, the study aims to identify biological markers that reflect dietary intake and its impact on metabolic health. The goal is to enhance dietary assessment methods and provide insights into how these beverages influence diabetes risk, ultimately helping individuals make informed dietary choices.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who consume sugar-sweetened or artificially sweetened beverages and are at risk for type 2 diabetes.
Not a fit: Patients who do not consume these types of beverages or who have already been diagnosed with type 2 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better dietary guidelines and personalized nutrition strategies that reduce the risk of type 2 diabetes.
How similar studies have performed: Previous research has shown promising results in using proteomic profiling to understand dietary impacts on health, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Haslam, Danielle — Brigham and Women's Hospital
- Study coordinator: Haslam, Danielle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.